A recently held meeting by the Genetic Metabolic Diseases Advisory Committee saw an 11-5 vote in favor of recommending the approval of arimoclomol. This investigative treatment was proposed for individuals with Niemann-Pick disease type C, a rare and fatal neurovisceral genetic disorder. The majority of committee advisors believed that the clinical and nonclinical data, along
Health
The FDA recently granted accelerated approval to afamitresgene autoleucel (afami-cel, Tecelra) for the treatment of advanced synovial sarcoma. This marks a significant milestone as afami-cel is the first engineered cell therapy indicated for a solid tumor. Synovial sarcoma is a rare soft-tissue cancer that predominantly affects individuals with unresectable or metastatic disease who have received
Recent research has unveiled a troubling connection between the levels of certain metals found in urine and an increased risk of cardiovascular disease (CVD) and all-cause mortality. The findings, based on the largest epidemiological study to date, shed light on the potential health implications of exposure to non-essential and essential metals. This groundbreaking study, conducted
The recently released proposed Medicare fee schedule for 2025 has raised concerns among healthcare professionals, as the Medicare “conversion factor” (CF) is at a historically low level. This decrease in the CF means that healthcare providers serving Medicare patients will face even lower reimbursement rates, leading to financial challenges and potential barriers to access to
In a groundbreaking move, the Centers for Medicare & Medicaid Services (CMS) have approved a proposal by North Carolina Governor Roy Cooper’s administration to implement a unique financial incentive program for hospitals in the state. This program aims to eliminate patients’ medical debt and implement policies to prevent future liabilities. Under the plan submitted by
The FDA has recently approved the Shield blood test for colorectal cancer (CRC) screening in adults over the age of 45 who are at average risk for the disease. Guardant Health has announced that this approval marks a significant milestone, as Shield is now the first blood test to be approved by the FDA as
The recent surge in reported cases of dengue fever across the Americas is a cause for concern. According to a recent Health Advisory from the CDC, the number of reported cases had already doubled this year, reaching a staggering 9.7 million by June 24. This increase in cases is alarming, especially considering that the region
The recent announcement by the VA’s top doctor at a New York psychedelic conference regarding the potential approval of MDMA-assisted therapy for PTSD sent shockwaves through the psychedelic community. The expectations for this groundbreaking approval quickly unraveled when FDA advisers voted overwhelmingly against the drug, citing flawed data, questionable research conduct, and potential safety and
A recent paper challenged the prevailing notion that the H5N1 bird flu in cattle always results in mild illness. The research conducted on nine farms revealed that cattle mortality rates were twice as high during outbreaks on certain farms. For instance, a farm in Ohio recorded 99 cow deaths during a 3-week period, which is
In the realm of social media, there is a rising trend of healthcare professionals using their platforms to advocate for important issues. One such example is Cardiothoracic ICU nurse Alexis Smith, who not only holds the title of Miss Kansas 2024 but also went viral for speaking out against unhealthy relationships and confronting her alleged